V015-1393 Screening compound: 4-[6-(2-methoxybenzoyl)-4-(4-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

V015-1393 Screening compound: 4-[6-(2-methoxybenzoyl)-4-(4-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine
V015-1393 Screening compound: 4-[6-(2-methoxybenzoyl)-4-(4-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-1393
4-[6-(2-methoxybenzoyl)-4-(4-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-1393

Molecular Formula

C26H28N4O4 (C26 H28 N4 O4)

Compound Name

4-[6-(2-methoxybenzoyl)-4-(4-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

IUPAC name

4-[6-(2-methoxybenzoyl)-4-(4-methylphenoxy)-5H6H7H8H-pyrido[43-d]pyrimidin-2-yl]morpholine

SMILES

Cc(cc1)ccc1Oc1c(CN(CC2)C(c(cccc3)c3OC)=O)c2nc(N2CCOCC2)n1

InChI

InChI=1S/C26H28N4O4/c1-18-7-9-19(10-8-18)34-24-21-17-30(25(31)20-5-3-4-6-23(20)32-2)12-11-22(21)27-26(28-24)29-13-15-33-16-14-29/h3-10H,11-17H2,1-2H3

InChI Key

LGYFWNFZCXKPLH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19908227

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

460.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.082

Distribution Coefficient, logD

4.082

Water Solubility, LogSw

-4.32

Polar Surface Area

62.044

Acid Dissociation Constant (pKa)

20.15

Base Dissociation Constant (pKb)

1.77

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

V015-1393 in Drug Discovery

Included in Screening Libraries

BRD4 Targeted Library (4534 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Others
  • Kinases

References: we are preparing a list of scientific research reports with V015-1393 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-1393?
Check Price and Availability of V015-1393, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-1393 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-1393
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-1393
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-1393 available by request